CEBPA and acute myeloid leukemia: Among AML patients with CEBPA mutations, 70% have both alleles affected, termed as CEBPA biallelically mutated (CEBPAbi) AML, where one allele usually carries an out-of-frame N-terminal mutation, while the other carries an in-frame C-terminal mutation [6, 12].